Table 2 Estimated marginal mean scores of clinical ratings in controls and Long COVID patients divided into two groups one with highly increased body temperature, lowered SpO2 and high nitro-oxidative stress (LC + O&NS) versus another group with fewer changes in these biomarkers (LC).

6.01 (0.82)^B,C

15.24 (0.61)^A,C

20.17 (0.70)^A,B

88.39

<0.0001

7.65 (1.27)^B,C

17.78 (0.94)^A,C

23.72 (1.08)^A,B

46.95

<0.0001

7.11 (1.66)^B,C

23.30 (1.24)^A,C

31.06 (1.42)^A,B

61.66

<0.0001

1.65 (0.29)^B,C

4.22 (0.21)^A,C

5.85 (0.25)^A,B

62.39

<0.0001

1.65 (0.34)^B,C

4.34 (0.26)^A,C

5.92 (0.29)^A,B

44.95

<0.0001

1.65 (0.33)^B,C

3.38 (0.25)^A

4.06 (0.28)^A

16.26

<0.0001

3.17 (0.61)^B,C

7.86 (0.46)^A,C

11.52 (0.53)^A,B

53.57

<0.0001

4.61 (1.01)^B,C

15.69 (0.76)^A,C

20.71 (0.87)^A,B

74.64

<0.0001

−1.167 (0.118)^B,C

0.043 (0.088)^A,C

0.766 (0.101)^A,B

77.78

<0.001

−1.157 (0.122)^B,C

0.139 (0.091)^A,C

0.623 (0.104)^A,B

64.53

<0.0001

−0.936 (0.141)^B,C

0.022 (0.105)^A

0.591 (0.121)^A

34.10

<0.0001

−1.036 (0.136)^B,C

0.167 (0.102)^A

0.519 (0.117)^A

40.42

<0.0001

−0.915 (0.143)^B,C

0.117 (0.107)^A,C

0.474 (0.123)^A,B

28.59

<0.0001

−0.532 (0.163)^B,C

0.074 (0.122)^A

0.257 (0.140)^A

7.22

0.002